| Literature DB >> 25463605 |
Biswajit Das1, Curtis Dobrowolski1, Abdel-Malek Shahir2, Zhimin Feng3, Xiaolan Yu3, Jinfeng Sha3, Nabil F Bissada2, Aaron Weinberg3, Jonathan Karn4, Fengchun Ye5.
Abstract
HIV patients with severe periodontitis have high levels of residual virus in their saliva and plasma despite effective therapy (HAART). Multiple short chain fatty acids (SCFAs) from periodontal pathogens reactivate HIV-1 in both Jurkat and primary T-cell models of latency. SCFAs not only activate positive transcription elongation factor b (P-TEFb), which is an essential cellular cofactor for Tat, but can also reverse chromatin blocks by inducing histone modifications. SCFAs simultaneously increase histone acetylation by inhibiting class-1/2 histone deacetylases (HDACs) and decrease repressive histone tri-methylation at the proviral LTR by downregulating expression of the class-3 HDAC sirtuin-1 (SIRT1), and the histone methyltransferases enhancer of Zeste homolog 2 (EZH2) and suppressor of variegation 3-9 homolog 1 (SUV39H1). Our findings provide a mechanistic link between periodontal disease and enhanced HIV-1 replication, and suggest that treatment of periodontal disease, or blocking the activities of SCFAs, will have a therapeutic benefit for HIV patients.Entities:
Keywords: EZH2; HIV-1 transactivation; P-TEFb; SIRT1; Short chain fatty acids
Mesh:
Substances:
Year: 2014 PMID: 25463605 PMCID: PMC4259832 DOI: 10.1016/j.virol.2014.10.033
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616